Synthesis and crystal structure of ((6R,7S)-3-ethyl-6-phenyl-6,7-dihydro-5H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazin-7-yl)(phenyl)methanone hemihydrate, 2(C19H18N4OS) ⋅ H2O
Author:
Ding Qichun1, Yang Ruya1, Yao Peipao1
Affiliation:
1. Department of Pharmacy, Zhangzhou Health Vocational College, Zhangzhou 363000, P.R. China
Abstract
AbstractC38H38N8O3S2, triclinic, P1̄ (no. 2), a = 10.1773(12) Å, b = 12.9096(15) Å, c = 15.1950(18) Å, α = 97.579(1)°, β = 97.967(1)°, γ = 109.835(1)°, V = 1825.2(4) Å3, Z = 2, Rgt(F) = 0.0523, wRref(F2) = 0.1412, T = 296.15 K.
Publisher
Walter de Gruyter GmbH
Subject
Inorganic Chemistry,Condensed Matter Physics,General Materials Science
Reference38 articles.
1. Unraveling the alkaline phosphatase inhibition, anticancer, and antileishmanial potential of coumarin-triazolothiadiazine hybrids: design, synthesis, and molecular docking analysis;Arch. Pharm. Chem. Life Sci,2016 2. Crystal structure of (1R,2S,3R,4S)-1-(6-(4-fluorophenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazin-3-yl)pentane-1,2,3,4,5-pentaol water (2:7);Z. Kristallogr. NCS,2009 3. Synthesis and antibacterial activity of 3,6-diaryl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines;Pharm. Chem. J,2016 4. Carboxylate surrogates enhance the antimycobacterial activity of UDP-galactopyranose mutase probes;ACS Infect. Dis,2016 5. OLEX2: a complete structure solution, refinement and analysis program;J. Appl. Crystallogr,2009
|
|